Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

NCT04011618 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: Ellagic Acid / Pomegranate Extract
DRUG: Placebo oral capsule

Sponsor

University of Guadalajara

Collaborators

[object Object]